National Center for Injury Prevention and Control Initial Review Group, 35394-35395 [E8-14158]
Download as PDF
<![CDATA[
35394
Federal Register / Vol. 73, No. 121 / Monday, June 23, 2008 / Notices
Mailstop F63, Atlanta, GA 30333, Telephone
(770) 488–4655.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: June 16, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–14088 Filed 6–20–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Jane
Suen, PhD, M.S., Executive Secretary, NCIPC
IRG, CDC, 4770 Buford Highway, NE., M/S
F–62, Atlanta, Georgia 30341, telephone 770/
488–4281.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: June 17, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–14077 Filed 6–20–08; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
National Center for Injury Prevention
and Control Initial Review Group
mmaher on PROD1PC70 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following teleconference meeting:
Name: National Center for Injury
Prevention and Control (NCIPC), Initial
Review Group (IRG).
Times and Date: 1 p.m.–1:30 p.m., July 11,
2008 (Open).1:30 p.m.–5 p.m., July 11, 2008
(Closed).
Place: Centers for Disease Control and
Prevention, Chamblee Campus, Building 106,
4770 Buford Highway, Atlanta, Georgia
30341. Toll Free: 888–793–2154, Participant
Passcode: 4424802.
Status: Portions of the meetings will be
closed to the public in accordance with
provisions set forth in section 552b(c)(4) and
(6), Title 5, U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to section
10(d) of Public Law 92–463.
Purpose: This group is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services, and the Director, CDC, concerning
the scientific and technical merit of grant and
cooperative agreement applications received
from academic institutions and other public
and private profit and nonprofit
organizations, including State and local
government agencies, to conduct specific
injury research that focuses on prevention
and control.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of individual research grant and
cooperative agreement applications
submitted in response to Fiscal Year 2008
Requests for Applications related to the
following individual research announcement:
RFA–EH–08–002, Program to Expand State or
Territorial Public Health Laboratory Capacity
for Newborn Bloodspot Screening to Include
Severe Combined Immune Deficiency (SCID)
(U01).
VerDate Aug<31>2005
01:51 Jun 21, 2008
Jkt 214001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Injury Prevention
and ControlInitial Review Group
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following teleconference meeting:
Name: National Center for Injury
Prevention and Control (NCIPC) Initial
Review Group (IRG).
Times And Date: 1 p.m.–1:30 p.m., July 8,
2008 (Open). 1:30 p.m.–6 p.m., July 8, 2008
(Closed).
Place: The teleconference will originate at
CDC, ChambleeCampus, Building 106, 4770
Buford Highway, Atlanta, Georgia 30341. To
participate, dial (888) 793–2154, and enter
passcode: 4424802.
Status: Portions of the meetings will be
closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and
(6), Title 5, U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Section
10(d) of Public Law 92–463.
Purpose: This group is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services, and the Director, CDC, concerning
the scientific and technical merit of grant and
cooperative agreement applications received
from academic institutions and other public
and private profit and nonprofit
organizations, including State and local
government agencies, to conduct specific
injury research that focuses on prevention
and control.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of individual research grant and
cooperative agreement applications
submitted in response to Fiscal Year 2008
Requests for Applications related to the
following individual research announcement:
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
‘‘Elimination of Health Disparities Through
Translation Research (R18), Request for
Application (RFA) CD08–001 for the National
Center for Injury Prevention and Control
Applications.’’
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Jane
Suen, PhD, M.S., Executive Secretary, NCIPC
IRG, CDC, 4770 Buford Highway, NE., M/S
F–62, Atlanta, Georgia 30341, telephone 770/
488–4281.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: June 16, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office,Centers for Disease Control and
Prevention.
[FR Doc. E8–14084 Filed 6–20–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Injury Prevention
and ControlInitial Review Group
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting:
Name: National Center for Injury
Prevention and Control (NCIPC) Initial
Review Group (IRG).
Times and Date: 9 a.m.–9:30 a.m., July 9,
2008 (Open); 9:30 a.m.–5 p.m., July 9, 2008
(Closed).
Place: Doubletree Hotel Atlanta-Buckhead,
3342 Peachtree Road, NE., Atlanta, Georgia
30326, Telephone: 404–231–1234.
Status: Portions of the meetings will be
closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and
(6), Title 5, U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Section
10(d) of Public Law 92–463.
Purpose: This group is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services, and the Director, CDC, concerning
the scientific and technical merit of grant and
cooperative agreement applications received
from academic institutions and other public
and private profit and nonprofit
organizations, including State and local
government agencies, to conduct
E:\FR\FM\23JNN1.SGM
23JNN1
Federal Register / Vol. 73, No. 121 / Monday, June 23, 2008 / Notices
specific injury research that focuses on
prevention and control.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of individual research grant and
cooperative agreement applications
submitted in response to Fiscal Year 2008
Requests for Applications related to the
following individual research announcement:
‘‘Elimination of Health Disparities Through
Translation Research (R18), Request for
Application (RFA) CD08–001 for the National
Center for Environmental Health
Applications.’’
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Jane
Suen, PhD, M.S., Executive Secretary, NCIPC
IRG, CDC, 4770 Buford Highway, NE., M/S
F–62, Atlanta, Georgia 30341, telephone 770–
488–4281.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: June 16, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–14158 Filed 6–20–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice Regarding Revisions to the
Laboratory Protocol To Measure the
Quantity of Nicotine Contained in
Smokeless Tobacco Products
Manufactured, Imported, or Packaged
in the United States
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services.
ACTION: Notice and request for public
comment.
AGENCY:
mmaher on PROD1PC70 with NOTICES
SUMMARY: The uniform protocol for the
analysis of nicotine, total moisture, and
pH in smokeless tobacco products,
VerDate Aug<31>2005
01:51 Jun 21, 2008
Jkt 214001
originally published in the Federal
Register in 1999 (64 FR 14086), ‘‘Notice
Regarding Requirement for Annual
Submission of the Quantity of Nicotine
Contained in Smokeless Tobacco
Products Manufactured, Imported, or
Packaged in the United States,’’ and
revised in the Federal Register on
March 14, 2008 (73 FR 13903),
implements the requirement of the
Comprehensive Smokeless Tobacco
Health Education Act (CSTHEA) of 1986
(15 U.S.C. 4401 et seq., Pub. L. 99–252)
that each entity manufacturing,
packaging, or importing smokeless
tobacco products shall annually provide
the Secretary of Health and Human
Services (HHS) with a specification of
the quantity of nicotine contained in
each smokeless tobacco product. CDC is
re-publishing the notice published in
the Federal Register on March 14, 2008
(73 FR 13903) concerning the revision of
the protocol for analysis of nicotine in
smokeless tobacco products (hereinafter
referred to as ‘‘Protocol’’) to (1) make a
technical change to correct the date
when the first report of information
under the revised Protocol is due; (2)
solicit public comments concerning a
change in the Protocol that increased
the volume of water in the pH
determination from 10 mL to 20 mL,
and (3) solicit public comments
concerning the addition of the following
commercial smokeless tobacco product
categories: Dry snuff portion packs,
snus, snus portion packs, and pellet or
compressed.
The Protocol as published in the
Federal Register on March 14, 2008 (73
FR 13903), remains in effect with the
technical correction to the date
described below.
Technical change: The language in
the March 14, 2008 notice stated that
‘‘The first report of information is due
June 30, 2008, with subsequent
submissions due by March 31 of each
year.’’ The first report date of
information should be 2009 so that the
sentence correctly reads: ‘‘The first
report of information is due June 30,
2009, with subsequent submissions due
by March 31 of each year.’’
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
35395
Written comments concerning
the change in the volume of liquid in
the pH determination and the addition
of four commercial smokeless tobacco
product categories must be received on
or before July 23, 2008.
ADDRESSES: Comments should be
marked ‘‘Comments on Revised Protocol
for Analysis of Nicotine’’ and mailed to
the Centers for Disease Control and
Prevention, National Center for Chronic
Disease Prevention and Health
Promotion, Office on Smoking and
Health, Attention: Matthew McKenna,
M.D., Director, 4770 Buford Highway
NE., MS K–50, Atlanta, Georgia 30341–
3724. Comments may be e-mailed to:
pir1@cdc.gov.
DATES:
FOR FURTHER INFORMATION CONTACT:
Matthew McKenna, M.D. Director,
Office on Smoking and Health,
Telephone: (770) 488–5701.
SUPPLEMENTARY INFORMATION: Several
smokeless tobacco product categories
have entered the U.S. smokeless tobacco
market since the implementation of the
protocol in 1999 including snus, low
moisture snuff sold in portion pouches,
and smokeless tobacco sold in a
compressed, pellet form. Some of the
new smokeless tobacco product
categories differ physically from
previous smokeless tobacco categories.
After evaluating information that has
recently come to the attention of the
Centers for Disease Control and
Prevention’s Office on Smoking and
Health (OSH) regarding low moisture
smokeless tobacco products packaged in
portion pouches, OSH conducted an
independent comparison of pH
measurements in a variety of low and
high moisture smokeless tobacco
products. The results of this
comparison, presented in Table 1,
indicate that there is an acceptable (less
than 2%) level of change in pH values
when measurements are taken with 20
mL deionized, distilled water
(Condition B) compared to 10 mL of
deionized, distilled water (Condition A).
Increasing the volume of water in the
mixture ensures that the matrix is
sufficiently fluid to facilitate ease of
measure.
E:\FR\FM\23JNN1.SGM
23JNN1
]]>Agencies
[Federal Register Volume 73, Number 121 (Monday, June 23, 2008)]
[Notices]
[Pages 35394-35395]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-14158]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Injury Prevention and ControlInitial Review
Group
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting:
Name: National Center for Injury Prevention and Control (NCIPC)
Initial Review Group (IRG).
Times and Date: 9 a.m.-9:30 a.m., July 9, 2008 (Open); 9:30
a.m.-5 p.m., July 9, 2008 (Closed).
Place: Doubletree Hotel Atlanta-Buckhead, 3342 Peachtree Road,
NE., Atlanta, Georgia 30326, Telephone: 404-231-1234.
Status: Portions of the meetings will be closed to the public in
accordance with provisions set forth in Section 552b(c)(4) and (6),
Title 5, U.S.C., and the Determination of the Director, Management
Analysis and Services Office, CDC, pursuant to Section 10(d) of
Public Law 92-463.
Purpose: This group is charged with providing advice and
guidance to the Secretary, Department of Health and Human Services,
and the Director, CDC, concerning the scientific and technical merit
of grant and cooperative agreement applications received from
academic institutions and other public and private profit and
nonprofit organizations, including State and local government
agencies, to conduct
[[Page 35395]]
specific injury research that focuses on prevention and control.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of individual research grant and
cooperative agreement applications submitted in response to Fiscal
Year 2008 Requests for Applications related to the following
individual research announcement: ``Elimination of Health
Disparities Through Translation Research (R18), Request for
Application (RFA) CD08-001 for the National Center for Environmental
Health Applications.''
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Jane Suen, PhD, M.S.,
Executive Secretary, NCIPC IRG, CDC, 4770 Buford Highway, NE., M/S
F-62, Atlanta, Georgia 30341, telephone 770-488-4281.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: June 16, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-14158 Filed 6-20-08; 8:45 am]
BILLING CODE 4163-18-P
